Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/7784| Title: | Raising the bar for market authorisation of new drugs |
| Authors: | Naci, H Cylus, J Vandoros, S Sato, A Perampaladas, K |
| Keywords: | Drug approval;Drug discovery;Drug industry;Europe;Evidence-based medicine;Drug legislation;Marketing of health services;Treatment outcome;United States;United States Food and Drug Administration |
| Issue Date: | 2012 |
| Publisher: | BMJ Publishing Group |
| Citation: | BMJ, 345, e4261, 2012 |
| Description: | © BMJ Publishing Group Ltd 2012 |
| URI: | http://www.ncbi.nlm.nih.gov/pubmed/22872693 http://bura.brunel.ac.uk/handle/2438/7784 |
| DOI: | http://dx.doi.org/10.1136/bmj.e4261 |
| ISSN: | 0959-8138 |
| Appears in Collections: | Economics and Finance Community Health and Public Health Dept of Economics and Finance Research Papers |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Fulltext.pdf | 232.23 kB | Adobe PDF | View/Open |
Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.